Previous Article | Next Article 
Journal of Virology, January 2000, p. 363-370, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Simplified Strategy for Detection of Recombinant
Human Immunodeficiency Virus Type 1 Group M Isolates by
gag/env Heteroduplex Mobility Assay
Leo
Heyndrickx,1
Wouter
Janssens,1,2,*
Léopold
Zekeng,3
Rosemary
Musonda,4
Séverin
Anagonou,5
Gert
Van der
Auwera,1
Sandra
Coppens,1
Katleen
Vereecken,1
Ko
De
Witte,1
Rian
Van
Rampelbergh,1
Maina
Kahindo,6
Linda
Morison,7
Francine E.
McCutchan,8
Jean K.
Carr,8
Jan
Albert,9
Max
Essex,10
Jaap
Goudsmit,11
Birgitta
Asjö,12
Mika
Salminen,13
Anne
Buvé,1
Study Group on
Heterogeneity of HIV Epidemics in African Cities,
and
Guido
van der
Groen1
Department of Microbiology, Institute of Tropical Medicine,
Antwerp,1 and The Flanders
Interuniversity Institute for Biotechnology (VIB),
Zwijnaarde,2 Belgium; Laboratoire de
Santé Hygiène Mobile, Ministère de la Santé,
Yaoundé, Cameroon3; Tropical
Diseases Research Centre, Ndola, Zambia4;
Programme National de Lutte contre le SIDA, Cotonou,
Bénin5; National
AIDS/STD Control Programme, Nairobi,
Kenya6; London School of Hygiene & Tropical Medicine, Department of Infections and Tropical
Diseases, London, United Kingdom7; Henry
M. Jackson Foundation, Rockville, Maryland8;
Swedish Institute for Infectious Disease Control,
Karolinska Institute, Stockholm, Sweden9;
Harvard Institute and the Department of Immunology
and Infectious Diseases, Harvard School of Public Health, Boston,
Massachusetts10; Department of Human
Retrovirology, Amsterdam, The Netherlands11;
National Centre for Research in Virology, University of
Bergen, Bergen, Norway12; and
Department of Chronic Viral Infections, National
Public Health Institute, Helsinki, Finland13
Received 10 May 1999/Accepted 22 September 1999
We developed a heteroduplex mobility assay in the gag
gene (gag HMA) for the identification of group M
subtypes A to H. The assay covers the region coding for amino
acid 132 of p24 to amino acid 20 of p7 (according to human
immunodeficiency virus type 1 [HIV-1] ELI, 460 bp). The
gag HMA was compared with sequencing and phylogenetic
analysis of an evaluation panel of 79 HIV-1 group M isolates isolated
from infected individuals from different geographic regions.
Application of gag HMA in combination with env
HMA on 252 HIV-1- positive plasma samples from Bénin, Cameroon,
Kenya, and Zambia revealed a high prevalence of a variety of
intersubtype recombinants in Yaoundé, Cameroon (53.8%);
Kisumu, Kenya (26.8%); and Cotonou, Bénin (41%); no
recombinants were identified among the samples from Ndola, Zambia. The
AGIbNG circulating recombinant form, as determined by
gag HMA, was found to be the most common intersubtype
recombinant in Yaoundé (39.4%) and Cotonou (38.5%). Using a
one-tube reverse transcriptase PCR protocol, this gag HMA
in combination with env HMA is a useful tool for
rapidly monitoring the prevalence of the various genetic subtypes as
well as of recombinants of HIV-1. Moreover, this technology can easily
be applied in laboratories in developing countries.
*
Corresponding author. Mailing address: Department of
Microbiology, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium. Phone: 32-3-247-63-28. Fax: 32-3-247-63-33. E-mail:
wjanssens{at}itg.be.

Members of the Study Group on Heterogeneity of HIV Epidemics in
African Cities include A. Buvé (coordinator), M. Laga, E.
Van
Dyck, W. Janssens, and L. Heyndrickx (Institute of Tropical
Medicine,
Antwerp, Belgium); M. Caraël (UNAIDS); S. Anagonou
(Programme
National de Lutte contre le SIDA, Bénin); M. Laourou
(Institut
National de Statistiques et d'Analyses Economiques,
Bénin); L. Kanhonou (Centre de Recherche en Reproduction Humaine
et en
Démographie, Bénin); L. Zekeng (Laboratoire de Santé
Hygiène Mobile, Cameroon); E. Akam and M. de Loenzien (Institut
de Formation et de Recherche en Démographiques, Cameroon);
S.-C.
Abega (Université Catholique d'Afrique Centrale,
Cameroon); M.
Kahindo (formerly National AIDS/STD Control
Programme, Kenya);
J. Chege and N. Rutenberg (The
Population Council, Nairobi); V.
Kimani (Department of Community
Health, University of Nairobi);
R. Musonda, T. Sukwa, and F. Kaona
(Tropical Diseases Research
Centre, Zambia); B. Auvert and E. Lagarde
(INSERM U88, Paris,
France); N. J. Robinson (formerly INSERM
U88, Paris, France);
B. Ferry and N. Lydié (Centre Français
sur la Population et
le Développement, Paris, France); and R. Hayes, L. Morison, H.
Weiss, and J. Glynn (London School of Hygiene and
Tropical Medicine,
London, United
Kingdom).
Journal of Virology, January 2000, p. 363-370, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Van Gulck, E. R. A., Ponsaerts, P., Heyndrickx, L., Vereecken, K., Moerman, F., De Roo, A., Colebunders, R., Van den Bosch, G., Van Bockstaele, D. R., Van Tendeloo, V. F. I., Allard, S., Verrier, B., Maranon, C., Hoeffel, G., Hosmalin, A., Berneman, Z. N., Vanham, G.
(2006). Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins. Blood
107: 1818-1827
[Abstract]
[Full Text]
-
Sengupta, S., Jana, S., Roy, P., Sarkar, K., Bhattacharya, S. K., Chakrabarti, S.
(2005). Phylogenetic Analysis of the p24-p7 Region of the Human Immunodeficiency Virus Type 1 gag Gene To Determine Subtype Distribution among Female Sex Workers in Calcutta, India. J. Clin. Microbiol.
43: 5787-5791
[Abstract]
[Full Text]
-
Krachmarov, C., Pinter, A., Honnen, W. J., Gorny, M. K., Nyambi, P. N., Zolla-Pazner, S., Kayman, S. C.
(2005). Antibodies That Are Cross-Reactive for Human Immunodeficiency Virus Type 1 Clade A and Clade B V3 Domains Are Common in Patient Sera from Cameroon, but Their Neutralization Activity Is Usually Restricted by Epitope Masking. J. Virol.
79: 780-790
[Abstract]
[Full Text]
-
Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., Petropoulos, C. J., Burton, D. R.
(2004). Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies. J. Virol.
78: 13232-13252
[Abstract]
[Full Text]
-
Roudinskii, N. I., Sukhanova, A. L., Kazennova, E. V., Weber, J. N., Pokrovsky, V. V., Mikhailovich, V. M., Bobkov, A. F.
(2004). Diversity of Human Immunodeficiency Virus Type 1 Subtype A and CRF03_AB Protease in Eastern Europe: Selection of the V77I Variant and Its Rapid Spread in Injecting Drug User Populations. J. Virol.
78: 11276-11287
[Abstract]
[Full Text]
-
Siddappa, N. B., Dash, P. K., Mahadevan, A., Jayasuryan, N., Hu, F., Dice, B., Keefe, R., Satish, K. S., Satish, B., Sreekanthan, K., Chatterjee, R., Venu, K., Satishchandra, P., Ravi, V., Shankar, S. K., Shankarappa, R., Ranga, U.
(2004). Identification of Subtype C Human Immunodeficiency Virus Type 1 by Subtype-Specific PCR and Its Use in the Characterization of Viruses Circulating in the Southern Parts of India. J. Clin. Microbiol.
42: 2742-2751
[Abstract]
[Full Text]
-
Njai, H. F., Van der Auwera, G., Ngong, C. A., Heyndrickx, L., Sawadago, S., Whittle, H., Nyambi, P., Colebunders, R., van der Groen, G., Janssens, W.
(2004). Development, Evaluation, and Validation of an Oligonucleotide Probe Hybridization Assay To Subtype Human Immunodeficiency Virus Type 1 Circulating Recombinant Form CRF02_AG. J. Clin. Microbiol.
42: 1428-1433
[Abstract]
[Full Text]
-
Soares, C. C., Volotao, E. M., Albuquerque, M. C. M., Nozawa, C. M., Linhares, R. E. C., Volokhov, D., Chizhikov, V., Lu, X., Erdman, D., Santos, N.
(2004). Genotyping of Enteric Adenoviruses by Using Single-Stranded Conformation Polymorphism Analysis and Heteroduplex Mobility Assay. J. Clin. Microbiol.
42: 1723-1726
[Abstract]
[Full Text]
-
Grenfell, B. T., Pybus, O. G., Gog, J. R., Wood, J. L. N., Daly, J. M., Mumford, J. A., Holmes, E. C.
(2004). Unifying the Epidemiological and Evolutionary Dynamics of Pathogens. Science
303: 327-332
[Abstract]
[Full Text]
-
Fischer, A., Lejczak, C., Lambert, C., Servais, J., Makombe, N., Rusine, J., Staub, T., Hemmer, R., Schneider, F., Schmit, J. C., Arendt, V.
(2004). Simple DNA Extraction Method for Dried Blood Spots and Comparison of Two PCR Assays for Diagnosis of Vertical Human Immunodeficiency Virus Type 1 Transmission in Rwanda. J. Clin. Microbiol.
42: 16-20
[Abstract]
[Full Text]
-
Sawadogo, S., Adje-Toure, C., Bile, C. E., Ekpini, R. E. A., Chorba, T., Nkengasong, J. N.
(2003). Field Evaluation of the gag-Based Heteroduplex Mobility Assay for Genetic Subtyping of Circulating Recombinant Forms of Human Immunodeficiency Virus Type 1 in Abidjan, Cote d'Ivoire. J. Clin. Microbiol.
41: 3056-3059
[Abstract]
[Full Text]
-
Kitrinos, K. M., Hoffman, N. G., Nelson, J. A. E., Swanstrom, R.
(2003). Turnover of env Variable Region 1 and 2 Genotypes in Subjects with Late-Stage Human Immunodeficiency Virus Type 1 Infection. J. Virol.
77: 6811-6822
[Abstract]
[Full Text]
-
Plantier, J.-C., Vergne, L., Damond, F., MBoup, S., MPoudi-NGole, E., Buzelay, L., Farfara, I., Brand, D., Peeters, M., Brun-Vezinet, F., Delaporte, E., Barin, F.
(2002). Development and Evaluation of a DNA Enzyme Immunoassay Method for env Genotyping of Subtypes A through G of Human Immunodeficiency Virus Type 1 Group M, with Discrimination of the Circulating Recombinant Forms CRF01_AE and CRF02_AG. J. Clin. Microbiol.
40: 1010-1022
[Abstract]
[Full Text]
-
Doukhan, L., Delwart, E.
(2001). Population Genetic Analysis of the Protease Locus of Human Immunodeficiency Virus Type 1 Quasispecies Undergoing Drug Selection, Using a Denaturing Gradient-Heteroduplex Tracking Assay. J. Virol.
75: 6729-6736
[Abstract]
[Full Text]
-
Moore, J. P., Parren, P. W. H. I., Burton, D. R.
(2001). Genetic Subtypes, Humoral Immunity, and Human Immunodeficiency Virus Type 1 Vaccine Development. J. Virol.
75: 5721-5729
[Full Text]
-
Agwale, S. M., Robbins, K. E., Odama, L., Saekhou, A., Zeh, C., Edubio, A., Njoku, O. M., Sani-Gwarzo, N., Gboun, M. F., Gao, F., Reitz, M., Hone, D., Folks, T. M., Pieniazek, D., Wambebe, C., Kalish, M. L.
(2001). Development of an env gp41-Based Heteroduplex Mobility Assay for Rapid Human Immunodeficiency Virus Type 1 Subtyping. J. Clin. Microbiol.
39: 2110-2114
[Abstract]
[Full Text]
-
de Baar, M. P., Timmermans, E. C., Bakker, M., de Rooij, E., van Gemen, B., Goudsmit, J.
(2001). One-Tube Real-Time Isothermal Amplification Assay To Identify and Distinguish Human Immunodeficiency Virus Type 1 Subtypes A, B, and C and Circulating Recombinant Forms AE and AG. J. Clin. Microbiol.
39: 1895-1902
[Abstract]
[Full Text]
-
Vidal, N., Peeters, M., Mulanga-Kabeya, C., Nzilambi, N., Robertson, D., Ilunga, W., Sema, H., Tshimanga, K., Bongo, B., Delaporte, E.
(2000). Unprecedented Degree of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Genetic Diversity in the Democratic Republic of Congo Suggests that the HIV-1 Pandemic Originated in Central Africa. J. Virol.
74: 10498-10507
[Abstract]
[Full Text]
-
Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., Bhattacharya, T.
(2000). Timing the Ancestor of the HIV-1 Pandemic Strains. Science
288: 1789-1796
[Abstract]
[Full Text]